FINAL RESULTS AND PHARMACOECONOMIC ANALYSIS OF A TRIAL COMPARING TWO NEOADJUVANT CHEMOTHERAPY (CT) REGIMENS FOLLOWED BY SURGERY IN PATIENTS WITH RESECTABLE NON-SMALL CELL LUNG CANCER (NSCLC): A PHASE II RANDOMISED STUDY BY THE EUROPEAN LUNG CANCER WORKING PARTY

被引：0

作者：

Berghmans, Thierry

Lafitte, Jean-Jacques ^{[1
]}

Giner, Vicente

Berchier, Marie-Claude

Scherpereel, Arnaud ^{[1
]}

Lewin, Daniel

Paesmans, Marianne

Meert, Anne-Pascale

Bosschaerts, Thierry ^{[2
]}

Leclercq, Nathalie

Sculier, Jean-Paul

机构：

[1] CHRU Lille, Lille, France

[2] Hop St Pierre, St Pierre, Belgium

来源：

关键词：

Non small cell lung carcinoma; Surgery; neoadjuvant chemotherapy; Cost-effectiveness;

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：S465 / S466

页数：2